Kadmon is a biotech firm dedicated to creating lifesaving therapies for patients with unmet medical needs. The company is developing a range of innovative products, with a focus on inflammatory and fibrotic diseases and immuno-oncology. Led by an experienced management team, Kadmon is rapidly emerging as a leader in the biopharmaceutical world, as it continues to make significant strides toward commercializing its cutting-edge treatments. With an impressive pipeline of groundbreaking therapies in development, Kadmon is poised for success in the years to come.